K. Deasy, H. Ibrahim, Mairead Mc Carthy, C. Fleming, James Dorgan, Yvonne Mc Carthy, C. Howlett, S. Twohig, Paul O'Regan, Laura Kirwan, Desmond M Murphy, Barry J Plant
{"title":"在一个 CF 单中心试点队列中,Elexacaftor/Tezacaftor/Ivacaftor(ETI)对前瞻性痰液收集和微生物学报告的实际影响。","authors":"K. Deasy, H. Ibrahim, Mairead Mc Carthy, C. Fleming, James Dorgan, Yvonne Mc Carthy, C. Howlett, S. Twohig, Paul O'Regan, Laura Kirwan, Desmond M Murphy, Barry J Plant","doi":"10.1183/23120541.acf-2023.15","DOIUrl":null,"url":null,"abstract":"","PeriodicalId":505181,"journal":{"name":"Adult Cystic Fibrosis","volume":"44 5","pages":""},"PeriodicalIF":0.0000,"publicationDate":"2023-12-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":"{\"title\":\"Real-world Elexacaftor/Tezacaftor/Ivacaftor(ETI) changes prospective sputum collection and microbiological reporting in a single centre pilot CF cohort.\",\"authors\":\"K. Deasy, H. Ibrahim, Mairead Mc Carthy, C. Fleming, James Dorgan, Yvonne Mc Carthy, C. Howlett, S. Twohig, Paul O'Regan, Laura Kirwan, Desmond M Murphy, Barry J Plant\",\"doi\":\"10.1183/23120541.acf-2023.15\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"\",\"PeriodicalId\":505181,\"journal\":{\"name\":\"Adult Cystic Fibrosis\",\"volume\":\"44 5\",\"pages\":\"\"},\"PeriodicalIF\":0.0000,\"publicationDate\":\"2023-12-01\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Adult Cystic Fibrosis\",\"FirstCategoryId\":\"1085\",\"ListUrlMain\":\"https://doi.org/10.1183/23120541.acf-2023.15\",\"RegionNum\":0,\"RegionCategory\":null,\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"\",\"JCRName\":\"\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Adult Cystic Fibrosis","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.1183/23120541.acf-2023.15","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
Real-world Elexacaftor/Tezacaftor/Ivacaftor(ETI) changes prospective sputum collection and microbiological reporting in a single centre pilot CF cohort.